Clinical Trial Update: sFlt-1/PlGF Ratio: Impact on the Management of Patients With Suspected Pre-eclampsia [NA]

View source ↗

Summary

A completed clinical trial evaluated whether the sFlt-1/PlGF biomarker ratio could influence clinical management in patients with suspected pre-eclampsia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pre-eclampsia

Snippet

Sponsor: Centre Hospitalier Universitaire de Nice | Conditions: Pre-Eclampsia | NA | Status: COMPLETED